BioPharma
Nabla & Takeda Expand Partnership on AI In Drug Development
Nabla Bio, the U.S. biotech firm, said on October 14, 2025, that it has signed a second major research partnership along with Takeda Pharmaceutical, the Japanese drugmaker, thereby deepening their usage of AI in drug development.
As per the new...
Business & Industry
AstraZeneca Plant Expansion to Double Production of Lokelma
AstraZeneca has gone on to announce a newly expanded manufacturing facility located in Coppell, Texas, U.S., which is going to double production of Lokelma for the advantages of patients across the U.S. as well as around the world.
This $445 million...
BioPharma
Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI
Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the...
News
Why Anti-Wrinkle Injections Are Gaining Popularity in Ireland
Over the past decade, Ireland has seen a significant rise in demand for non-surgical cosmetic treatments — and at the forefront of this trend are anti-wrinkle injections. Once associated primarily with celebrities and the ultra-wealthy, these treatments are now...
News
Driving Excellence in Pharmaceutical Production with Advanced Pharmaceutical Cooling Systems
Introduction
In pharmaceutical manufacturing, every degree matters. Process cooling is not merely a support function—it's a critical control point that directly impacts product stability, batch consistency, and regulatory compliance. As the UK and European pharmaceutical industry continues to evolve with...
Clinical Trials
AstraZeneca and Daiichi Report Datroway Efficacy for TNBC
Datroway, a cancer drug developed by AstraZeneca and Daiichi Sankyo, has demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) in the TROPION-Breast02 Phase III trial. The...
BioPharma
Lonza Widens Cell and Gene Therapy Suite with New Products
Lonza widens cell and gene therapy suite by way of launching of two new products, which are - TheraPEAK AmpliCell Cytokines as well as TheraPEAK 293-GT Medium.
The additions happened to be aimed at elevating the scalability as well as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















